This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.
https://www.barrons.com/articles/pfizer-stock-covid-antiviral-51636111795
Updated Nov. 5, 2021 9:19 americium ET / Original Nov. 5, 2021 7:30 americium ET
- Order Reprints
- Print Article
Pfizer banal changeable higher aft beardown results for its Covid-19 antiviral.
Jonas Roosens/BELGA/AFP via Getty ImagesPfizer banal soared aft the institution said its Covid-19 pill chopped the hazard of hospitalization oregon decease by 89% successful a proceedings of high-risk non-hospitalized adults, besting by a important borderline the efficacy of Merck‘s highly-touted Covid-19 pill molnupiravir.
Shares of Pfizer (ticker: PFE) jumped 12.2% successful premarket trading Friday, portion Merck (MRK) shares dropped 8.6%.
The...
/466399676-5bfc38f146e0fb00511d6e3c.jpg)
English (US) ·